|
US2019022147A1
|
|
Treatment of Glioma by Amniotic Fluid Stem Cells and Exosomes Derived Thereof
|
|
US2018360882A1
|
|
Perispinal perfusion by administration of T regulatory cells alone or in combination with angiogenic cell therapies
|
|
US2018344899A1
|
|
Enhancement of nucleus pulposus regeneration by enhanced perfusion of perispinal area by combination drug, gene and cellular therapies
|
|
US2018340145A1
|
|
Generation of autologous immune modulatory cells for treatment of neurological conditions
|
|
US2018334664A1
|
|
Regeneration of corpus cavernosal tissue
|
|
US2018085405A1
|
|
Treatment of stroke by amniotic fluid derived stem cell conditioned media and products derived thereof
|
|
US2018071342A1
|
|
Inducing and accelerating post-stroke recovery by administration of amniotic fluid derived stem cells
|
|
US2018015127A1
|
|
Methods for treatment of premature ovarian failure and ovarian aging using regenerative cells
|
|
US2017354686A1
|
|
Adipose derived immunomodulatory cells for immunotherapy of recurrent spontaneous abortions
|
|
US2018325959A1
|
|
Methods of treating erectile dysfunction
|
|
US2017290887A1
|
|
Cell based therapy for female sexual dysfunction
|
